The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...

Between July 1 and Sept. 30, Washington’s Department of Ecology issued over $6.6 million in fines and penalties of $1,000 to 31 businesses, including four in Clark County, according to a Tuesday news ...

A federal bankruptcy court on November 18 formally approved Purdue’s $7.4 billion Chapter 11 plan to settle thousands of opioid-related lawsuits. The plan requires (1) a $6.5 billion contribution from ...

Nov 12 (Reuters) - OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 billion settlement resolving claims that the drugmaker's ...

The Supreme Court blocked an earlier version of Purdue’s bankruptcy settlement. Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

Added 4,306,363 Teva shares, an estimated $75.64 million trade based on the average quarterly price for Q3 2025 Transaction represents a 0.68% increase in reportable U.S. equity assets under ...

In October 2024, Questex announced a new direction for its life sciences events, including consolidating several events down to six, uniting life sciences professionals that span marketing, medical ...

Aucta Pharmaceuticals Inc. has opened its new corporate headquarters in Basking Ridge following a $4.6 million acquisition of the 52,000-square-foot office space. Aucta Pharmaceuticals specializes in ...

BERNARDS – Aucta Pharmaceuticals’ new corporate headquarters in the Basking Ridge section of the township will have its grand opening on Sept. 22. Kislak, a commercial real estate brokerage firm, ...

After months of searching for strategic options, Adaptimmune is offloading its cell therapies to a global pharma, which plans to offer jobs to about half of the biotech’s employees. Once the deal ...